ES2117008T3 - Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia. - Google Patents

Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.

Info

Publication number
ES2117008T3
ES2117008T3 ES91905529T ES91905529T ES2117008T3 ES 2117008 T3 ES2117008 T3 ES 2117008T3 ES 91905529 T ES91905529 T ES 91905529T ES 91905529 T ES91905529 T ES 91905529T ES 2117008 T3 ES2117008 T3 ES 2117008T3
Authority
ES
Spain
Prior art keywords
amperozide
therapy
schizophrenia
resistant
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905529T
Other languages
English (en)
Inventor
Anders Bjork
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Application granted granted Critical
Publication of ES2117008T3 publication Critical patent/ES2117008T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN METODO PARA TRATAR A UN PACIENTE QUE SUFRA DE ESQUIZOFRENIA RESISTENTE A LA TERAPIA MEDIANTE LA ADMINISTRACION AL PACIENTE DE UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE AMPEROCIDA.
ES91905529T 1990-03-01 1991-02-27 Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia. Expired - Lifetime ES2117008T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/487,547 US5013735A (en) 1990-03-01 1990-03-01 Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide

Publications (1)

Publication Number Publication Date
ES2117008T3 true ES2117008T3 (es) 1998-08-01

Family

ID=23936183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905529T Expired - Lifetime ES2117008T3 (es) 1990-03-01 1991-02-27 Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.

Country Status (8)

Country Link
US (1) US5013735A (es)
EP (1) EP0517787B1 (es)
JP (1) JP3243514B2 (es)
AT (1) ATE167398T1 (es)
DE (1) DE69129623T2 (es)
DK (1) DK0517787T3 (es)
ES (1) ES2117008T3 (es)
WO (1) WO1991012805A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300422A (en) * 1991-12-04 1994-04-05 Case Western Reserve University Screening method for controlling agranulocytosis
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
WO2008005368A2 (en) * 2006-06-30 2008-01-10 Abbott Laboratories Piperazines as p2x7 antagonists
US20080139573A1 (en) * 2006-12-08 2008-06-12 Copharm Treatment of resistant Schizophrenia and other CNS disorders
JP7321114B2 (ja) * 2019-04-26 2023-08-04 ユニ・チャーム株式会社 吸収性物品用の流動体の配置方法及び吸収性物品

Also Published As

Publication number Publication date
EP0517787A1 (en) 1992-12-16
JP3243514B2 (ja) 2002-01-07
JPH05504957A (ja) 1993-07-29
DE69129623D1 (de) 1998-07-23
DE69129623T2 (de) 1998-12-17
DK0517787T3 (da) 1999-04-06
US5013735A (en) 1991-05-07
ATE167398T1 (de) 1998-07-15
WO1991012805A1 (en) 1991-09-05
EP0517787B1 (en) 1998-06-17

Similar Documents

Publication Publication Date Title
ES2166381T3 (es) Tratamiento de enfermedades vasculares hiperproliferativas.
ES2127819T3 (es) Tratamiento de la degeneracion macular.
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
IN172468B (es)
DK0567576T3 (da) Behandling af neoplastiske sygdomme med interleukin-10
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
DE69300321D1 (de) Behandlung neurodegenerativer Erkrankungen.
KR950010156B1 (en) Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
DK0445280T3 (da) Terapeutisk middel og fremgangsmåde til inhibering af vaskularisering af tumorer
DE3268024D1 (en) 0-alkyl-0-carbamoyl-glycero-phospho-cholines and process for their preparation
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE69218200D1 (de) Behandlung von leberkrebs
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
NO984198L (no) FremgangsmÕte for behandling av aggresjon
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
SE8306384D0 (sv) Farmaceutisk komposition
EA199800818A1 (ru) Способ лечения бессонницы
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
RU1821745C (en) Method for prognosticating effectiveness of efferent therapeutic treatment of patients suffering from immunocomplex diseases
RU93035807A (ru) Способ лечения юношеского эпифизиолиса

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 517787

Country of ref document: ES